NASDAQ:ATEC Alphatec (ATEC) Stock Forecast, Price & News $12.97 -0.08 (-0.61%) (As of 09/29/2023 08:52 PM ET) Add Compare Share Share Today's Range$12.87▼$13.2750-Day Range$12.40▼$17.7952-Week Range$8.53▼$19.14Volume1.22 million shsAverage Volume1.11 million shsMarket Capitalization$1.56 billionP/E RatioN/ADividend YieldN/APrice Target$22.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Alphatec MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside69.6% Upside$22.00 Price TargetShort InterestBearish8.89% of Float Sold ShortDividend StrengthN/ASustainability-1.67Upright™ Environmental ScoreNews Sentiment0.01Based on 7 Articles This WeekInsider TradingSelling Shares$3.40 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.39) to ($0.93) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.63 out of 5 starsMedical Sector108th out of 970 stocksSurgical & Medical Instruments Industry17th out of 99 stocks 4.5 Analyst's Opinion Consensus RatingAlphatec has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $22.00, Alphatec has a forecasted upside of 69.6% from its current price of $12.97.Amount of Analyst CoverageAlphatec has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.89% of the float of Alphatec has been sold short.Short Interest Ratio / Days to CoverAlphatec has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in Alphatec has recently increased by 5.51%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAlphatec does not currently pay a dividend.Dividend GrowthAlphatec does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAlphatec has received a 37.18% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Cervical implants", "Medical screws", and "Lumbar spinal stenosis treatment instruments" products. See details.Environmental SustainabilityThe Environmental Impact score for Alphatec is -1.67. Previous Next 2.2 News and Social Media Coverage News SentimentAlphatec has a news sentiment score of 0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Alphatec this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for ATEC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows9 people have added Alphatec to their MarketBeat watchlist in the last 30 days. This is an increase of 125% compared to the previous 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alphatec insiders have sold 5,865.83% more of their company's stock than they have bought. Specifically, they have bought $56,982.00 in company stock and sold $3,399,449.00 in company stock.Percentage Held by Insiders29.12% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions67.19% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Alphatec are expected to grow in the coming year, from ($1.39) to ($0.93) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alphatec is -8.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alphatec is -8.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Alphatec (NASDAQ:ATEC) StockAlphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. It manufactures and sells implants and instruments through third-party suppliers. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform; Sigma PTP Access and Patient Positioning System; split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; EOS imaging system that provides full-body imaging; spinal implants and fixation systems; and NanoTec and Calibrate PSX, as well as various standalone implants for height restoration and stabilization. It also provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix, a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM; AlphaGRAFT Demineralized Bone Matrix comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives in the United States and internationally. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.Read More ATEC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ATEC Stock News HeadlinesSeptember 29, 2023 | americanbankingnews.comAlphatec Holdings, Inc. (NASDAQ:ATEC) CEO Patrick Miles Sells 59,375 SharesSeptember 29, 2023 | americanbankingnews.comInsider Selling: Alphatec Holdings, Inc. (NASDAQ:ATEC) CEO Sells 60,000 Shares of StockOctober 2, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.September 23, 2023 | americanbankingnews.comAlphatec Holdings, Inc. (NASDAQ:ATEC) CEO Sells $801,000.00 in StockSeptember 23, 2023 | americanbankingnews.comInsider Selling: Alphatec Holdings, Inc. (NASDAQ:ATEC) CEO Sells $808,800.00 in StockSeptember 22, 2023 | seekingalpha.comAlphatec CEO sells shares worth $2.42M - filingSeptember 22, 2023 | americanbankingnews.comAlphatec (NASDAQ:ATEC) Stock Price Down 4.8% on Insider SellingAugust 31, 2023 | msn.comAlphatec Holdings (ATEC) Price Target Increased by 10.03% to 23.63October 2, 2023 | Stansberry Research (Ad)U.S. "Shadow Banks" About to Blow up again?Analyst who called Lehman crash says our biggest calamities (1907, 1929, 2007, etc) all start in the same spot--and it’s about to happen again. More here.August 10, 2023 | msn.comAlphatec: Price Reversal Diverges From Economic Levers That Are Well In Situ (Rating Upgrade)August 10, 2023 | seekingalpha.comAlphatec Holdings, Inc. 2023 Q2 - Results - Earnings Call PresentationAugust 5, 2023 | msn.comHC Wainwright & Co. Reiterates Alphatec Holdings (ATEC) Buy RecommendationAugust 5, 2023 | msn.comStifel Maintains Alphatec Holdings (ATEC) Buy RecommendationAugust 4, 2023 | markets.businessinsider.comAlphatec Holdings (ATEC) Receives a Buy from H.C. WainwrightAugust 4, 2023 | markets.businessinsider.comExpert Ratings for Alphatec HoldingsAugust 3, 2023 | finance.yahoo.comATEC Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Revenue and Adjusted EBITDA GuidanceJuly 6, 2023 | msn.comAlphatec Holdings (ATEC) Price Target Increased by 6.76% to 21.48June 29, 2023 | fool.comAlphatec (NASDAQ: ATEC)June 27, 2023 | msn.comLake Street Maintains Alphatec Holdings (ATEC) Buy RecommendationJune 27, 2023 | msn.comAlphatec (ATEC) Surges 8.8%: Is This an Indication of Further Gains?June 26, 2023 | benzinga.comAlphatec Holdings shares are trading higher after Lake Street maintained a Buy rating on the stock and raised its price target from $20 to $32.June 26, 2023 | markets.businessinsider.comLake Street Maintains Buy Rating for Alphatec Holdings: Here's What You Need To KnowJune 26, 2023 | benzinga.comLake Street Maintains Buy on Alphatec Holdings, Raises Price Target to $32June 22, 2023 | marketwatch.comEurope Spinal Implants Market Research Report 2023 Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030June 17, 2023 | seekingalpha.comATEC Alphatec Holdings, Inc.June 13, 2023 | msn.comTivoli Audio partners with Alphatec to launch smart audio products in IndiaJune 6, 2023 | finance.yahoo.comMissed Out On Intuitive Surgical's Boom? This Stock May Be a Better Buy NowSee More Headlines Receive ATEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter. Email Address ATEC Company Calendar Last Earnings8/03/2023Today10/01/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:ATEC CUSIP02081G10 CIK1350653 Webwww.atecspine.com Phone(760) 431-9286Fax800-922-1356Employees705Year Founded1990Price Target and Rating Average Stock Price Forecast$22.00 High Stock Price Forecast$32.00 Low Stock Price Forecast$12.00 Forecasted Upside/Downside+69.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($1.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-152,150,000.00 Net Margins-39.56% Pretax Margin-39.62% Return on EquityN/A Return on Assets-29.97% Debt Debt-to-Equity RatioN/A Current Ratio2.16 Quick Ratio1.30 Sales & Book Value Annual Sales$421.81 million Price / Sales3.70 Cash FlowN/A Price / Cash FlowN/A Book Value($0.35) per share Price / Book-37.06Miscellaneous Outstanding Shares120,319,000Free Float85,282,000Market Cap$1.56 billion OptionableNot Optionable Beta1.27 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Patrick S. Miles (Age 57)Exec. Chairman, CEO & Pres Comp: $1.59MMr. J. Todd Koning (Age 50)Exec. VP & CFO Comp: $815.29kMr. David P. Sponsel (Age 44)Exec. VP of Sales Comp: $848.19kMr. Craig E. Hunsaker (Age 59)Exec. VP of People and Culture Comp: $909.33kMr. Eric Dasso (Age 50)Exec. VP of Adjunctive Technologies Comp: $1MMr. Tyson Eliot Marshall (Age 49)Gen. Counsel & Corp. Sec. Mr. Ali Shorooghi (Age 37)Sr. VP of Marketing Mr. Jonathan Allen (Age 63)Exec. VP of Commercial Operations Mr. Scott Lish (Age 42)Sr. VP of R&D Dr. Luiz PimentaChief Medical OfficerMore ExecutivesKey CompetitorsAtriCureNASDAQ:ATRCOrthofix MedicalNASDAQ:OFIXSurmodicsNASDAQ:SRDXIntegra LifeSciencesNASDAQ:IARTGlobus MedicalNYSE:GMEDView All CompetitorsInsiders & InstitutionsPatrick MilesSold 59,375 sharesTotal: $771,875.00 ($13.00/share)Patrick MilesSold 60,000 sharesTotal: $750,600.00 ($12.51/share)Patrick MilesSold 60,000 sharesTotal: $801,000.00 ($13.35/share)Patrick MilesSold 60,000 sharesTotal: $808,800.00 ($13.48/share)David H MowrySold 9,500 sharesTotal: $137,370.00 ($14.46/share)View All Insider TransactionsView All Institutional Transactions ATEC Stock - Frequently Asked Questions Should I buy or sell Alphatec stock right now? 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ATEC shares. View ATEC analyst ratings or view top-rated stocks. What is Alphatec's stock price forecast for 2023? 7 brokers have issued 12-month target prices for Alphatec's stock. Their ATEC share price forecasts range from $12.00 to $32.00. On average, they expect the company's share price to reach $22.00 in the next year. This suggests a possible upside of 69.6% from the stock's current price. View analysts price targets for ATEC or view top-rated stocks among Wall Street analysts. How have ATEC shares performed in 2023? Alphatec's stock was trading at $12.35 at the start of the year. Since then, ATEC shares have increased by 5.0% and is now trading at $12.97. View the best growth stocks for 2023 here. Are investors shorting Alphatec? Alphatec saw a increase in short interest in September. As of September 15th, there was short interest totaling 6,700,000 shares, an increase of 5.5% from the August 31st total of 6,350,000 shares. Based on an average trading volume of 1,230,000 shares, the short-interest ratio is currently 5.4 days. Currently, 8.9% of the company's shares are sold short. View Alphatec's Short Interest. When is Alphatec's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our ATEC earnings forecast. How were Alphatec's earnings last quarter? Alphatec Holdings, Inc. (NASDAQ:ATEC) posted its quarterly earnings data on Thursday, August, 3rd. The medical technology company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.13. The medical technology company had revenue of $116.92 million for the quarter, compared to analyst estimates of $110.18 million. What ETFs hold Alphatec's stock? ETFs with the largest weight of Alphatec (NASDAQ:ATEC) stock in their portfolio include Jacob Forward ETF (JFWD), Innovator IBD 50 ETF (FFTY), SPDR S&P Health Care Equipment ETF (XHE) and Invesco Dorsey Wright Healthcare Momentum ETF (PTH).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has Alphatec issued on next quarter's earnings? Alphatec issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $462.00 million-$462.00 million, compared to the consensus revenue estimate of $451.05 million. What is Pat Miles' approval rating as Alphatec's CEO? 19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend. What other stocks do shareholders of Alphatec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alphatec investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), Sorrento Therapeutics (SRNE), Catalyst Pharmaceuticals (CPRX), (GBSN) (GBSN), Idera Pharmaceuticals (IDRA), Athersys (ATHX), Anavex Life Sciences (AVXL) and BioCryst Pharmaceuticals (BCRX). What is Alphatec's stock symbol? Alphatec trades on the NASDAQ under the ticker symbol "ATEC." How do I buy shares of Alphatec? Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Alphatec's stock price today? One share of ATEC stock can currently be purchased for approximately $12.97. How much money does Alphatec make? Alphatec (NASDAQ:ATEC) has a market capitalization of $1.56 billion and generates $421.81 million in revenue each year. The medical technology company earns $-152,150,000.00 in net income (profit) each year or ($1.51) on an earnings per share basis. How many employees does Alphatec have? The company employs 705 workers across the globe. How can I contact Alphatec? Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The official website for the company is www.atecspine.com. The medical technology company can be reached via phone at (760) 431-9286, via email at ir@alphatecspine.com, or via fax at 800-922-1356. This page (NASDAQ:ATEC) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alphatec Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.